Neutrophil phenotypes and functions in cancer: A consensus statement bit.ly/38Y2r37 From @DanielaQuail, Bristol Neutrophil Lab laylo brown Andrés Hidalgo ilaria Malanchi Taha Vivek Mittal Mikael Pittet Udalova Lab - Genomics of Inflammation Arturo Zychlinsky Mikala Egeblad kubeslab and colleagues

Check out this new paper from IMP graduate student Sara Schad in Jedd Wolchok's lab Jedd Wolchok! Sara discovers and characterizes an interesting population of polyfunctional antigen-reactive CD4+CD8+ T cells within tumors. rupress.org/jem/article-ab…

I’m thrilled that the 3rd chapter of our explorations of #COVID19 in patients with cancer is out today in Cancer Cell! Thread (1/24): cell.com/cancer-cell/fu…

#FinancialToxicity: "This idea that #affordability is the barrier between someone getting a #cancer tx vs paying to keep their lights on, it's shocking. We live in the best society, we have the most resources...yet we still have pts that are routinely falling through the cracks."

Congratulations to our Memorial Sloan Kettering Cancer Center DoM colleagues who have been named recipients of the 2022 Conquer Cancer, the ASCO Foundation Career Development Award! We're so proud of Allison Betof Warner, MD, PhD, Steve Maron, Angela Green, MD, MSc, and Adam J. Schoenfeld! ASCO #ASCO2022 #cancerresearch #oncology

1/ My exceptional ID colleague Mini Kamboj is the winner of the Willet F. Whitmore Award for Clinical Excellence Memorial Sloan Kettering Cancer Center. This award is given to a clinician whose talent, dedication, and compassion reflect the standards set by Willet F. Whitmore, MD, during his more

👏 RT and congratulate Dr. Jedd Wolchok (Jedd Wolchok) who is the #ASCO22 David A. Karnofsky Memorial Award and Lecture recipient for his outstanding contributions to the field of cancer #immunotherapy. mskcc.org/news-releases/… ASCO

Even before mRNA was used for a covid vaccine, researchers BioNTech SE were using the technology to develop customized cancer treatments. A vaccine for cancer…? Not quite, but close. Here is how it works:

📺 Median life expectancy for someone with metastatic #melanoma has improved from 7 months to 6 years. “That doesn’t mean our work is over,” said #PICINetwork member Jedd Wolchok Memorial Sloan Kettering Cancer Center, who discusses #immunotherapy’s advances. CURE Today bit.ly/3PB3INU

🎉 Congratulations to → Parker Bridge Fellows, supported in partnership with The V Foundation for Cancer Research Katie Campbell Kenneth Hu Derek Oldridge Bingfei Yu → Parker Senior Fellow #Ya-TingWang → Parker Scholars #GabrielAbrilRodriguez (Parker RISE Scholar) Inaki Etxeberria #LouaiLabanieh #DarwinYe

Our own Dr. Ushma Neill said it best – summer internship season is our favorite time of year! On this #NationalInternDay, we're giving a shout-out to this year's intern class (a.k.a the groundbreaking scientists of tomorrow 🔬). bit.ly/3z2E0MB

Thrilled to receive an NIH NIAID News DP2 New Innovator Award #NIHHighRisk to study newly identified Thetis cells in early life immune tolerance. We are recruiting! Memorial Sloan Kettering Cancer Center Weill Cornell Medicine Immunology & Microbial Pathogenesis (IMP) Program Exciting projects on #mucosaltolerance #infantimmunity #Aire DM/email!

Pancreatic cancer is one of the leading causes of cancer death in our nation. Thankfully, doctors at MSK are testing a new treatment using a therapeutic mRNA vaccine that uses the same tech as the COVID-19 vaccine. Read more about the promising results. bit.ly/3QAD4Fn

Please let your young colleagues know about this great funding opportunity!

Very happy to share our study describing a new lineage of RORgt+ antigen presenting cells – Thetis cells – that instruct Treg differentiation and tolerance to gut microbes during early life! nature.com/articles/s4158… Brilliant teamwork led by @BlossomAkagbosu and @ZTayyebi 🧵 1/

Pleased to announce the opening of my lab at Memorial Sloan Kettering Cancer Center. Recruiting postdocs and at other levels. peledlab.org

A combination of checkpoint inhibitor #immunotherapy drugs (nivolumab & relatlimab) given before #melanoma surgery shows promise, a phase 2 clinical trial published in nature finds. After ~2 years most patients remained cancer free. mskcc.org/news/new-check…

New in Nature Cancer from Memorial Sloan Kettering Cancer Center Drs Chris Barker and Nadeem Riaz: Combining #radiotherapy with activation of macrophages yields potent, abscopal effects in mouse tumor models... this may be ready for translation into early clinical trials. 📰nature.com/articles/s4301…

We are so proud to share the incredible work of Chi Nguyen and her coauthors that was published in Cell sciencedirect.com/science/articl…

So proud of Susan DeWolf and team for this incredible paper! science.org/doi/10.1126/sc…